Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma

por Zhou, Nan, Lei, Chuan-Fen, Tan, Si-Rui, Huang, Qi-Yue, Zhang, Shun-Yu, Liang, Zheng-Xin, Gou, Hong-Feng
Publicado 2023